|
Orthologous residues
|
|
CSFR (human): Y723‑p, CSFR (mouse): Y721‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, western blotting
|
|
Relevant cell lines - cell types - tissues:
FDCP-1 (myeloid)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
MCSF
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Effect of modification (process):
cell differentiation, altered
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
PIK3R1 (mouse)
|
SH2
|
Induces
|
molecular association, regulation, enzymatic activity, induced
|
cell differentiation, altered
|
pull-down assay, in vitro
|
|
PLCG1 (mouse)
|
SH2
|
Induces
|
molecular association, regulation, enzymatic activity, induced
|
cell differentiation, altered
|
pull-down assay, in vitro
|
|
PLCG1 (mouse)
|
SH2
|
Induces
|
molecular association, regulation
|
|
yeast two-hybrid
|
|